ErythroPOietin alfa to prevent mortality and reduce severe disability in critically ill TRAUMA patients: a multicentre, stratified, double blind, placebo randomised controlled trial. (The EPO-TRAUMA trial)

  • French, Craig (Primary Chief Investigator (PCI))
  • Nichol, Alistair (Chief Investigator (CI))
  • Bellomo, Rinaldo (Chief Investigator (CI))
  • Cooper, Jamie (Chief Investigator (CI))
  • Bailey, Michael (Chief Investigator (CI))
  • Higgins, Lisa (Chief Investigator (CI))
  • McArthur, Colin (Chief Investigator (CI))
  • Hodgson, Carol (Chief Investigator (CI))
  • Gabbe, Belinda (Associate Investigator (AI))
  • Duranteau, Jacques (Associate Investigator (AI))
  • Presneill, Jeffrey (Associate Investigator (AI))
  • Rosenfeld, Jeffrey (Associate Investigator (AI))
  • Napolitano, Lena (Associate Investigator (AI))
  • Skrifvars, Markus (Associate Investigator (AI))
  • Reade, Michael (Associate Investigator (AI))
  • Pettila, Ville (Associate Investigator (AI))

Project: Research

Project Details

Short titleEPO-TRAUMA
AcronymEPO-TRAUMA
StatusActive
Effective start/end date1/04/19 → 31/03/26

Funding

  • Department of Health and Aged Care (Australia): A$3,509,303.10